Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2022-11-28
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Testing of Collagen Peptide Drink
NCT04996043
Efficacy Evaluation of Triple up® Collagen Drink on Skin Condition
NCT04225091
Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors
NCT04456829
Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging
NCT01557205
Evaluating Light-tissue Reaction and Transdermal Drug Delivery by Multiphoton Microscopy
NCT01355328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACS Topical Treatment Group
25 participants, measured at Week 0, 2, 4.
ACS Topical Treatment Group
The topical group applied the ACS cream to the face twice daily (morning and night) for 4 weeks.
Topical Placebo Group
25 participants, measured at Week 0, 2, 4.
Topical Placebo Group
The topical group applied the cream (without ACS) to the face twice daily (morning and night) for 4 weeks.
ACS Oral Treatment Group
25 participants, measured at Week 0, 2, 4, 8, 12.
ACS Oral Treatment Group
The oral group ingested one ACS capsule twice daily after breakfast and dinner for 12 weeks.
Oral Placebo Group
25 participants, measured at Week 0, 2, 4, 8, 12.
Oral Placebo Group
The oral group ingested one capsule (without ACS) twice daily after breakfast and dinner for 12 weeks.
ACS Oral Treatment + ACS Topical Treatment Group
25 participants, measured at Week 0, 2, 4, 8, 12.
Oral Treatment + Topical Treatment Group
The combination group used both the topical and oral ACS products for 12 weeks.
ACS Oral Treatment + Topical Placebo Group
25 participants, measured at Week 0, 2, 4, 8, 12.
Oral Treatment + Topical Placebo Group
The combination group used both the topical and oral products without ACS for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACS Topical Treatment Group
The topical group applied the ACS cream to the face twice daily (morning and night) for 4 weeks.
Topical Placebo Group
The topical group applied the cream (without ACS) to the face twice daily (morning and night) for 4 weeks.
Oral Treatment + Topical Treatment Group
The combination group used both the topical and oral ACS products for 12 weeks.
ACS Oral Treatment Group
The oral group ingested one ACS capsule twice daily after breakfast and dinner for 12 weeks.
Oral Placebo Group
The oral group ingested one capsule (without ACS) twice daily after breakfast and dinner for 12 weeks.
Oral Treatment + Topical Placebo Group
The combination group used both the topical and oral products without ACS for 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Subjects diagnosed with skin diseases, cirrhosis, or chronic renal failure by a -physician.
* Individuals with known allergies to cosmetics, drugs, or food.
* Pregnant or breastfeeding women.
* Individuals taking medication for chronic diseases.
* Subjects who, within 12 weeks prior to the test, have undergone laser facial treatments, chemical peels, or experienced prolonged sun exposure (more than 3 hours of direct sunlight in a week).
* Students taught by the investigator.
* Individuals unwilling to allow the publication of photos of the experimental results.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chia Nan University of Pharmacy ＆ Science
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chia Nan University of Pharmacy ＆ Science
Tainan City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TSMHIRB22-111-A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.